Epoch Biodesign

Epoch Biodesign

Private
LondonEnergy & Sustainabilityhttps://epochbiodesign.com/

Last Round

Venture -

Series Unknown

Mar 25, 2026

Total Funding Raised

$33.8M

Company Overview

Epoch Biodesign is a biotechnology company that develops AI-designed enzymes for the biorecycling of mixed plastics and textiles.

Sector

Energy & Sustainability

Verticals

Circular Economy, Biotechnology, Sustainable Materials, Waste Management

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

enzymatic recyclingbiorecyclingplastic eating enzymessynthetic biologyAI for biologycomputational protein designenzyme engineeringadvanced recyclingchemical recyclingtextile recyclingplastic depolymerizationNylon recyclingPolyester recyclingcircular economywaste-to-chemicalssustainable materialstechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epoch Biodesign Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Epoch Biodesign Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Venture - Series UnknownMar 25, 2026
GrantMar 5, 2025
Series AMar 5, 2025
SeedJun 22, 2022
Pre SeedJan 13, 2021

Key People

Founding team and executive leadership

Jacob Nathan

Founder CEO

Founding Team

Epoch Biodesign Investors

Notable investors and investment history

InvestorRounds
Innovate UKGrant
Amadeus Capital PartnersSeed
Mundi VenturesSeries A
Ascension VenturesPre Seed
Happiness CapitalSeries A, Venture - Series Unknown
ExtantiaVenture - Series Unknown, Series A
Plug & Play VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Launched Europe's first nylon 6,6 biorecycling demonstration plant.

  • Apr 2, 2026

    Total funding surpasses $50 million to scale operations.

Epoch Biodesign Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epoch Biodesign Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epoch Biodesign's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range53
Year Founded2019
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.